Rhinitis medicamentosa – preventable disease

Abstract

Aim of the study – analysis of modern ideas about the pathogenesis of rhinitis medicamentosa. The authors consider the factors causing changes in inflammatory nature and leading to rhinitis medicamentosa. The comparative estimation of modern means of pharmacotherapy was made. On the basis of literature and clinical research data, it is concluded that Otrivin has a much more gentle effect and contributes less to the development of rhinitis medicamentosa.

Keywords

• rhinitis medicamentosa
• nasal congestion
• otrivin
• nasal mucosa inflammation
• local decongestants